Viveve Medical (NASDAQ:VIVE) Shares Gap Up to $0.93

Share on StockTwits

Shares of Viveve Medical Inc (NASDAQ:VIVE) gapped up before the market opened on Wednesday . The stock had previously closed at $0.93, but opened at $0.93. Viveve Medical shares last traded at $0.92, with a volume of 96,428 shares traded.

VIVE has been the subject of a number of research reports. ValuEngine cut Viveve Medical from a “buy” rating to a “hold” rating in a research note on Saturday, November 23rd. Maxim Group reissued a “hold” rating on shares of Viveve Medical in a research note on Friday, August 9th. Finally, LADENBURG THALM/SH SH raised Viveve Medical from a “neutral” rating to a “buy” rating in a report on Tuesday. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $2.24.

The stock has a market cap of $1.25 million, a P/E ratio of -0.01 and a beta of -0.04. The firm has a 50-day simple moving average of $3.58 and a two-hundred day simple moving average of $1.67.

Viveve Medical (NASDAQ:VIVE) last released its quarterly earnings results on Thursday, November 7th. The company reported ($13.51) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($16.00) by $2.49. Viveve Medical had a negative return on equity of 2,979.48% and a negative net margin of 429.71%. The company had revenue of $1.05 million for the quarter. As a group, analysts anticipate that Viveve Medical Inc will post -69 EPS for the current year.

In other news, major shareholder Goldman Sachs Group Inc sold 92,425 shares of the stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $4.81, for a total value of $444,564.25. 5.20% of the stock is owned by corporate insiders.

A hedge fund recently bought a new stake in Viveve Medical stock. FNY Investment Advisers LLC bought a new position in shares of Viveve Medical Inc (NASDAQ:VIVE) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 16,136 shares of the company’s stock, valued at approximately $71,000. FNY Investment Advisers LLC owned 1.10% of Viveve Medical as of its most recent SEC filing. 32.96% of the stock is currently owned by hedge funds and other institutional investors.

About Viveve Medical (NASDAQ:VIVE)

Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components.

Read More: Depreciation

Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.